Europe Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - Regional Analysis - by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymp

Europe Gastric Cancer Diagnostic Procedure Market Forecast to 2028- Regional Analysis- by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer), and Country

The Europe gastric cancer diagnostic procedure market was valued at US$ 464.72 million in 2022 and is projected to reach US$ 674.76 million by 2028. It is estimated to grow at a CAGR of 6.4% from 2022 to 2028.

Rise in Prevalence of Gastrointestinal Diseases Fuels Europe Gastric Cancer Diagnostic Procedure Market

Heartburn, inflammatory bowel diseases (IBD), inflammatory bowel syndrome (IBS), constipation, and diarrhea are among the common digestive problems. Gastrointestinal (GI) diseases account for substantial healthcare utilization and spending. The stomach is lined with a mucous membrane composed of cells and glands. The cells are prone to inflammation, leading to peptic ulcers, which may potentially develop into gastric cancer. Problems caused by stomach acid backflowing into the esophagus, known as gastroesophageal reflux disease (GERD), also increase the risk of developing gastric cancer. Despite declining incidence and mortality during the last decades, stomach cancer is perceived as one of the main health challenges. The prevalence of irritable bowel syndrome (IBS) has increased across the region in the last few decades. In contrast to a decline in the overall incidence of gastric cancer, it has surged among young adults in the last few decades. Thus, the increasing prevalence of gastrointestinal (GI) disease results in a high risk of developing gastric cancer, which drives the growth of the gastric cancer diagnostic procedures market.

Europe Gastric Cancer Diagnostic Procedure Market Overview

The Europe gastric cancer diagnostic procedure market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global gastric cancer diagnostic procedure market. The market in Europe is expected to witness significant growth during the forecast period due to factors such as the high incidence of stomach cancer and Helicobacter pylori infection, growth in the geriatric population, and efforts made by various institutes to spread awareness of gastric cancer. Germany is one of the fastest-growing markets for gastric cancer diagnostic procedures in Europe. According to The Robert Koch Institute, H. pylori and Epstein-Barr virus infections are reported to be the major cause of stomach cancer. Germany reports a high incidence of H. pylori infection. According to a study published in Clinical Microbiology and Infection Journal (ELSEVIER) in 2020, H. pylori infected ~25% of the total population in Germany and caused gastritis that becomes more complicated with gastric adenocarcinoma.

Exhibit: Europe Gastric Cancer Diagnostic Procedure Market Revenue and Forecast to 2028 (US$ Million)

Europe Gastric Cancer Diagnostic Procedure Market Segmentation

The Europe gastric cancer diagnostic procedure market is segmented into healthcare provider, symptom type, body fluid, procedure, offering, disease indication, and country.

Based on healthcare provider, the Europe gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The hospitals segment held the largest market share in 2022. In terms of body fluid, the Europe gastric cancer diagnostic procedure market is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. The blood segment held the largest market share in 2022. The Europe gastric cancer diagnostic procedure market, by offering, is segmented into instruments, reagents & consumables, and services. The reagents & consumables segment held the largest market share in 2022.

Based on diagnostic procedure, the Europe gastric cancer diagnostic procedure market is categorized into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics, immunoassays, and others. The imaging segment held the largest share of the market in 2022. The Europe gastric cancer diagnostic procedure market, based on disease condition, is bifurcated into early gastric cancer and advanced type gastric cancer. The advanced type gastric cancer segment held a larger market share in 2022.

Based on country, the Europe gastric cancer diagnostic procedure market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Germany dominated the market in this region in 2022.

Agilent Technologies Inc, Atlas-Link Biotech Co Ltd, BioMerieux SA, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, Myraid Genetics Inc, Thermo Fisher Scientific Inc, and Vela Diagnostics Holding Pte Ltd. are the leading companies operating in the Europe gastric cancer diagnostic procedure market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe gastric cancer diagnostic procedure Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe gastric cancer diagnostic procedure Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe gastric cancer diagnostic procedure market trends and outlook coupled with the factors driving the Europe gastric cancer diagnostic procedure Market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution